Your browser doesn't support javascript.
loading
Copper signaling axis as a target for prostate cancer therapeutics.
Safi, Rachid; Nelson, Erik R; Chitneni, Satish K; Franz, Katherine J; George, Daniel J; Zalutsky, Michael R; McDonnell, Donald P.
Affiliation
  • Safi R; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina.
  • Nelson ER; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina.
  • Chitneni SK; Department of Radiology, Duke University, Durham, North Carolina.
  • Franz KJ; Department of Chemistry, Duke University, Durham, North Carolina.
  • George DJ; Divisions of Medical Oncology and Urology, Duke University, Durham, North Carolina.
  • Zalutsky MR; Department of Radiology, Duke University, Durham, North Carolina.
  • McDonnell DP; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina. Donald.McDonnell@duke.edu.
Cancer Res ; 74(20): 5819-31, 2014 Oct 15.
Article in En | MEDLINE | ID: mdl-25320179

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Signal Transduction / Copper / Disulfiram / Antineoplastic Agents Limits: Animals / Humans / Male Language: En Journal: Cancer Res Year: 2014 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Signal Transduction / Copper / Disulfiram / Antineoplastic Agents Limits: Animals / Humans / Male Language: En Journal: Cancer Res Year: 2014 Document type: Article Country of publication: Estados Unidos